Neogen Chemicals Limited — Important, 10-04-2025: General Updates

Dr. Harin Haridas Kanani has completed an inter-se transfer of 13,38,250 equity shares from Mr. Haridas Thakarshi Kanani by way of a gift, now constituting 5.07% of Neogen Chemicals' paid-up capital. This transaction is exempt under Regulation 10(1)(a)(ii) of the Takeover Regulations, ensuring that the overall holding of the Promoter and Promoter Group remains unchanged. Post-transaction, Dr. Kanani's ownership rises to 33,38,250 shares, representing 12.65% of the total share capital. This strategic transfer emphasizes the continuity of management within the company, enabling potential stability and a strong governance structure moving forward. Investors should watch closely for how this shift in shareholding could influence Neogen's strategic direction and operations.